| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.30B | 18.64B | 16.67B | 13.53B | 10.72B | 7.07B |
| Gross Profit | 15.19B | 14.67B | 13.15B | 10.49B | 8.21B | 5.48B |
| EBITDA | 8.19B | 7.87B | 7.01B | 5.18B | 3.63B | 2.29B |
| Net Income | 4.07B | 3.78B | 3.99B | 2.22B | 293.00M | 90.00M |
Balance Sheet | ||||||
| Total Assets | 39.68B | 39.91B | 38.83B | 34.77B | 31.17B | 30.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.33B | 3.05B | 3.93B | 4.43B | 2.21B | 2.20B |
| Total Debt | 16.21B | 15.60B | 16.65B | 16.46B | 17.11B | 18.23B |
| Total Liabilities | 21.39B | 21.72B | 22.41B | 21.49B | 22.09B | 22.34B |
| Stockholders Equity | 18.29B | 18.19B | 16.42B | 13.27B | 4.68B | 4.37B |
Cash Flow | ||||||
| Free Cash Flow | 4.69B | 4.64B | 3.08B | 2.67B | 2.62B | 1.35B |
| Operating Cash Flow | 5.53B | 5.36B | 5.26B | 3.45B | 2.94B | 1.61B |
| Investing Cash Flow | -1.55B | -1.42B | -2.41B | -904.00M | -359.00M | -5.56B |
| Financing Cash Flow | -4.79B | -4.86B | -3.38B | -388.00M | -2.61B | 4.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥9.10T | 37.56 | 25.14% | 1.01% | 9.44% | 28.08% | |
78 Outperform | ¥186.25B | 24.59 | 27.95% | 1.97% | 14.57% | 15.03% | |
74 Outperform | ¥56.12B | 13.67 | ― | 3.22% | 13.57% | 0.34% | |
54 Neutral | ¥123.72B | 21.20 | 7.81% | 1.78% | 3.39% | 7.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |